Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Policy + Initiatives

    Smithfield Outbreak: CDC Director Gives Contradictory Testimony on White House Interference

    By Global Biodefense StaffOctober 16, 2020
    Share
    Facebook LinkedIn Reddit Email

    U.S. Senator Tammy Baldwin (D-WI), Ranking Member of the Senate Employment and Workforce Safety Subcommittee, is calling for a Senate Health, Education, Labor and Pensions (HELP) Committee hearing following a New York Times report that revealed Centers for Disease Control and Prevention (CDC) Director Dr. Robert Redfield failed to disclose his conversations with the White House in his testimony at a recent HELP Committee hearing, and in a follow up conversation with Senator Baldwin.

    Senator Baldwin has been expressing deep concern regarding the CDC’s irregular process of responding to COVID-19 exposure at the Smithfield Foods Sioux Falls Pork Plant, one of the nation’s largest meatpacking centers. Following the CDC’s visit to the plant in April, the agency issued an Epi Aid report containing recommendations outlining how the plant can reduce disease transmission among workers. However, that document was immediately withdrawn and then watered down in a final version that was posted on CDC’s website. In the revised document, the CDC framed its science-based recommendations as purely optional by inserting phrases in directives such as “if feasible,” “consider,” and “if possible.”

    On September 23, CDC Director Robert Redfield testified before the Senate HELP Committee. Under questioning from Senator Baldwin, Dr. Redfield testified that he had no contact with the Department of Agriculture (USDA), the White House, or Smithfield about this matter, which contradicted his own CDC officials who have confirmed an April 22 phone call between the CDC Director and the USDA Secretary. Redfield also claimed the changes were made simply to clarify that the recommendations were advisory and not regulatory requirements, although previous CDC Epi Aids do not include similar weakening phrases. 

    After the hearing, Baldwin and members of the Senate and House sent a letter to Trump administration officials at the Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), and the National Institute for Occupational Safety and Health (NIOSH), to better understand why the changes were made from Version 1 of the CDC recommendations to Version 2 and who influenced the process. In a separate letter to USDA Secretary Sonny Perdue, the lawmakers requested documents outlining any communication between USDA and CDC or Smithfield concerning the development of guidance for Smithfield.

    On September 30, Dr. Redfield informed Senator Baldwin that, contrary to his previous testimony, his office was in contact with both USDA and the Department of Labor (DOL) about the Smithfield outbreak during the time that CDC was working on the safety recommendations.

    Last week, Baldwin and her colleagues sent a letter to DOL Secretary Eugene Scalia to request information about his department’s involvement with the CDC recommendations to the Smithfield plant in April 2020. 

    The New York Times recently reported that Marc Short, who is Vice President Mike Pence’s chief of staff, “directed Dr. Redfield, the C.D.C. director, to soften the language of the report, reducing the agency’s recommendations to suggestions.” 

    Dr. Redfield did not disclose this conversation when Senator Baldwin asked him at the September 23 hearing if he had any contact with the White House regarding the report. Dr. Redfield also did not mention the reported conversation with the Vice President’s chief of staff during the follow-up conversation with Baldwin on September 30.  

    In today’s letter to HELP Committee Chairman Lamar Alexander (R-TN), Ranking Member Patty Murray (D-WA), and Employment and Workplace Safety Subcommittee Chairwoman Susan Collins (R-ME), Baldwin is calling for a HELP Committee hearing with Dr. Redfield, USDA Secretary Sonny Perdue, and DOL Secretary Scalia regarding the Trump administration’s failure to address COVID-19 outbreaks at our nation’s meatpacking facilities.

    In her letter, Senator Baldwin writes: “The Senate Health, Education, Labor and Pensions (HELP) Committee has held numerous hearings to better understand the impact of this virus, and the role that our federal agencies play in research, prevention, treatment, and preparation for future pandemics. We are now more than seven months into this fight, and we have yet to hold a hearing about the impact of this virus on workers. This is unacceptable, especially given the recent reporting and revelations regarding industry efforts to influence public health recommendations made by the CDC.”

    She continues, “I am extremely concerned that the effort from CDC to change their recommendations represent not a regulatory clarification, but an effort to improve the public perception of meatpacking companies that did not want to be implicated or viewed as endangering workers.”

    “Dr. Redfield was not truthful when he came before the HELP Committee on September 23rd. Now there is evidence that he did not mention an important conversation he had with the Vice President’s Chief of Staff when he spoke with me in a follow-up conversation we had after the hearing. There is a pattern of dishonesty and a failure to tell the truth from the CDC Director and the Committee should hold a hearing to allow the truth to be shared with the American people.”

    The full letter is available here. 

    COVID-19 Editor Pick Epidemiology Infection Prevention + Control Public Health Emergency SARS-CoV-2
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleFDA Approves First Ebola Therapeutic
    Next Article The Mental Health Impact of Pandemics for Front Line Health Care Staff

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy